Profile
BDSI ZTS TAK HLN TEVA NBIX
Company Name BioDelivery Sciences International, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $577.05M $82.06B $43.45B $42.15B $19.37B $14.77B
Employees 0.20K 14.10K 49.28K 25.41K 35.00K 1.45K
CEO Mr. Herm Cukier Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Dr. Kevin C. Gorman Ph.D.
Ratings
BDSI ZTS TAK HLN TEVA NBIX
Quant Rating Score 5 3 2 3 1 3
Quant Rating Strong Buy Neutral Sell Neutral Strong Sell Neutral
Trading
BDSI ZTS TAK HLN TEVA NBIX
Last Close $5.59 $179.84 $13.77 $9.23 $17.1 $146.8
High 52 $5.59 $200.09 $16.32 $9.23 $17.4 $147.46
Low 52 $5.59 $145.54 $12.6 $7.78 $8.12 $101.19
Price vs. 52 Week High 0 % -10.12 % -15.63 % 0 % -1.72 % -0.45 %
Price vs. 52 Week Low 0 % 23.57 % 9.29 % 18.64 % 110.59 % 45.07 %
Total Return
BDSI ZTS TAK HLN TEVA NBIX
1 Month Return 0 % 1.92 % 6.66 % 9.49 % 5.17 % 9.3 %
3 Month Return 0 % 13.52 % 5.68 % 9.23 % 23.82 % 7.95 %
6 Month Return 0 % -6.1 % -5.68 % 12.97 % 43.58 % 3.27 %
9 Month Return 0 % 15.26 % 2.27 % 18.49 % 110.59 % 38.4 %
YTD Return 0 % -8.88 % -3.5 % 12.15 % 63.79 % 11.41 %
1 Year Return 0 % -4.69 % -11.79 % 6.28 % 103.09 % 44.99 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDSI ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 0.93 % 4.08 % 2.12 % - -
Dividend Paid and Capex Coverage Ration (TTM) 98.88 % 1.76 % 0.92 % - 3.3 % 20.82 %
Dividend Per Share (TTM) - 1.67 % 0.56 % 0.15 % - -
Payout Ratio (TTM) - 29.95 % 199.34 % - - -
Growth
BDSI ZTS TAK HLN TEVA NBIX
Asset Growth 35.31 % -4.28 % 8.25 % -2.18 % -1.2 % 37.27 %
Gross Profit Growth 8.74 % 3.7 % -16.6 % 5.85 % 9.64 % 26.06 %
Revenue Growth 6.54 % 5.74 % 5.87 % 4.09 % 6.16 % 26.76 %
Revenue 3 Year 83.22 % 31.98 % 33.13 % 13.9 % -6.92 % 71.93 %
Revenue 5 Year 457.26 % 53.64 % 149.89 % 32.87 % -23.33 % 308.36 %
Revenue 10 Year 1300.87 % 103.1 % 154.38 % 32.87 % -40.82 % 44100.16 %
EBIT Growth 12.57 % 6.27 % 7.34 % 37.26 % -84.52 % 0.76 %
Net Income Growth 230.05 % 10.88 % -54.56 % -1.04 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share 253.23 % 47.55 % -61.74 % -8.67 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share 165.69 % 71.94 % 62.27 % 59.66 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share 199.76 % 404.24 % 36.33 % 59.66 % -133.42 % 470.4 %
Operating Income Growth 12.57 % 6.27 % 7.34 % 37.26 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) 64.27 % 23.06 % -34.47 % -16.48 % -13.96 % 14.88 %
Operating 3 Year CFG 204.07 % 14.12 % -36.76 % 22.08 % 10.09 % 62.6 %
Operating 5 Year CFG 139.51 % 37.69 % 139.61 % 118.54 % -48.98 % 275.6 %
Operating 10 Year CFG 148.34 % 274.61 % 335.67 % 118.54 % -67.94 % 1000.37 %
EPS Growth 226.92 % 12.64 % -54.92 % - 76.42 % 59.01 %
EPS Diluted Growth 241.67 % 12.92 % -54.86 % - 76.42 % 58.33 %
Book Value Per Share 67.72 % 15.34 % 13.54 % 1.38 % -5.72 % 28.15 %
Share Holder 3 Year Equity Growth Per Share 286.17 % 36.7 % 40.38 % -36.6 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share 652.54 % 139.55 % 73.27 % -39.41 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share 1149.88 % 476.36 % 197.1 % -39.41 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % 1.95 % -85.58 % - -
Dividend 3 Year Growth Per Share - 87.76 % 1.19 % -83.69 % - -
Dividend 5 Year Growth Per Share - 198.29 % - -66.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % 103.93 % -66.42 % -100 % -
Debt Growth -25.06 % -15.91 % 24.67 % -9.43 % -6.53 % 62.95 %
Free Cash Flow Growth 62.7 % 22.25 % -53.54 % -20.06 % -19.19 % 11.99 %
Updated On 31 Dec 2021 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Dec 2023
Profitability
BDSI ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 85.98 % 69.2 % 66.54 % 60.04 % 48.99 % 97.78 %
Return on Assets TTM 26.14 % 16.66 % 0.95 % - -1.15 % 10.65 %
Return on Equity TTM 57.33 % 48.41 % 2.06 % 6.53 % -6.86 % 17.45 %
Return on Capital Employed TTM 15.33 % 25.86 % 3.22 % - 3.75 % 17.05 %
Net Income Per EBT TTM 286.48 % 80.07 % 293.72 % 64.62 % 59.18 % 78.68 %
EBT Per Ebit TTM 79.79 % 92.82 % 11.92 % 82.52 % -76.63 % 99.89 %
EBIT Per Revenue TTM 22.27 % 36.83 % 9.65 % 18.08 % 6.79 % 23.73 %
Cash Flow To Debt Ratio TTM 69.8 % 36.43 % 14.47 % - 8.57 % 118.01 %
Receivables Turnover TTM 2.93 6.75 6.11 - 4.63 4.4
Payables Turnover TTM 2.88 6.64 4.46 - 3.35 0.5
Inventory Turnover TTM 0.99 1.01 1.18 - 2.07 1.18
Fixed Asset Turnover TTM 9575.13 % 251.27 % 214.28 % - 267.75 % 572.67 %
Asset Turnover TTM 51.36 % 60.87 % 28.22 % - 37.45 % 57.08 %
Operating Cash Flow Per Share TTM 0.4 5.24 452.66 - 1.5 6.47
Free Cash Flow Per Share TTM 0.39 3.82 146.27 - 1.04 6.16
Cash Per Share TTM 110.66 % 431.22 % 29177.57 % 22.71 % 266.34 % 1213.03 %
Operating Cash Flow Sales Ratio TTM 24.62 % 27.47 % 16.66 % - 10.51 % 32.56 %
Free Cash Flow Operating Cash Flow Ratio TTM 98.99 % 72.95 % 32.31 % - 69.66 % 95.2 %
Cash Flow Coverage Ratios TTM 69.8 % 36.43 % 14.47 % - 8.57 % 118.01 %
Price To Free Cash Flows Ratio TTM 14.21 46.89 29.1 - 16.51 24.05
Price To Operating Cash Flows Ratio TTM 14.07 34.33 4.68 - 11.4 22.7
Price Cash Flow Ratio TTM 14.07 34.33 4.68 - 11.4 22.7
Income Statement (TTM)
BDSI ZTS TAK HLN TEVA NBIX
Revenue $0.17B $8.54B $4263.76B $11.3B $15.85B $1.89B
Gross Profit $0.14B $5.83B $2321.31B $6.96B $7.65B $1.85B
Gross Profit Ratio 85.98% 68.28% 54.44% 61.6% 48.25% 97.9%
EBITDA $0.04B $3.56B $1254.52B $2.81B $4.27B $0.42B
Net Income $0.08B $2.34B $144.07B $1.05B $-0.56B $0.25B
EPS Diluted 0.82 5.07 91.16 0.11 -0.5 2.47
Balance Sheet (MRQ)
BDSI ZTS TAK HLN TEVA NBIX
Long Term Debt $0.05B $6.56B $4476.5B $8.8B $18.48B $0.26B
Total Liabilities $0.14B $9.3B $7834.79B $17.33B $35.35B $1.02B
Total Equity $0.19B $4.99B $7274.01B $16.73B $8.13B $2.23B
Total Investments $-0.06B $0.02B $683.22B $0.07B $0.01B $0.94B
Total Debt $0.06B $6.8B $5463.39B $9.46B $20.15B $0.43B
Total Assets $0.32B $14.29B $15108.79B $34.06B $43.48B $3.25B
Cash Flow Statement (TTM)
BDSI ZTS TAK HLN TEVA NBIX
Net Income $0.08B $2.34B $144.07B $1.05B $-0.62B $0.25B
Inventory $-0.01B $-0.36B $-115.74B $-0.13B $-0.15B $0.01B
Dividends Paid $0B $-0.69B $-287.19B $-0.39B $0B $0B
Operating Cash Flow $0.04B $2.35B $640.32B $1.72B $1.37B $0.39B
Capital Expenditure $-0B $-0.73B $-480.73B $-0.34B $-0.53B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.9
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.45
AKAN Akanda Corp. 1.63
ALIM Alimera Sciences, Inc. 5.57
ALVO Alvotech 11.59
ALVOW Alvotech 2.59
AMPH Amphastar Pharmaceuticals, Inc. 42.48
AMRX Amneal Pharmaceuticals, Inc. 7.44
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 63.25
AQST Aquestive Therapeutics, Inc. 3.82
ASRT Assertio Holdings, Inc. 1.505
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 16.72
AYTU Aytu BioPharma, Inc. 2.7
ETFs With Exposure to BDSI
Ticker ETF Name Weight Percentage Price
PQSG PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF 0.2 72.5283
STSB iShares Factors US Small Blend Style ETF 0.07 47.635
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
Unlock